<PAGE>




                                   EXHIBIT 31.

                  CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER
                       PURSUANT TO RULES 13a-14 AND 15d-14
                     OF THE SECURITIES EXCHANGE ACT OF 1934

I, Raghu Kilambi,  Chief Executive  Officer and Chief Financial Officer of Swiss
Medica, Inc. (the "Company"), certify that:

         I have reviewed this  quarterly  report on Form 10-QSB of Swiss Medica,
Inc.

         Based on my  knowledge,  this  quarterly  report  does not  contain any
untrue  statement of a material fact or omit to state a material fact  necessary
to make the  statements  made,  in light of the  circumstances  under which such
statements  were made, not misleading with respect to the period covered by this
quarterly report.

         Based on my knowledge,  the financial  statements,  and other financial
information included in the report,  fairly present in all material respects the
financial condition,  results of operations and cash flows of the Company as of,
and for, the periods, presented in the report.

         I am responsible for establishing and maintaining  disclosure  controls
and  procedures  (as  defined in Exchange  Act Rules  13a-14 and 15d-14) for the
Company and have:

(a)              designed such  disclosure  controls and  procedures,  or caused
                 such disclosure controls and procedures to be designed under my
                 supervision,  to ensure that material  information  relating to
                 the Company, including its consolidated  subsidiaries,  is made
                 known  to me by  others  within  those  entities,  particularly
                 during  the  period  in  which  the  periodic  report  is being
                 prepared;
(b)              evaluated  the   effectiveness  of  the  Company's   disclosure
                 controls  and  procedures  and  presented  in this  report  our
                 conclusions about the effectiveness of the disclosure  controls
                 and  procedures,  as of the end of the  period  covered by this
                 quarterly report based on such evaluation; and
(c)              disclosed in this quarterly  report any change in the Company's
                 internal control over financial  reporting that occurred during
                 the Company's  most recent fiscal  quarter that has  materially
                 affected,  or is reasonably  likely to materially  affect,  the
                 Company's internal control over financial reporting; and

I have disclosed,  based on our most recent  evaluation of internal control over
financial reporting, to the Company's auditors and to the audit committee of the
board of directors (or persons  fulfilling  the  equivalent  function):

          (i)  all significant deficiencies in the design or operation of
               internal control over financial reporting which are reasonably
               likely to adversely affect the Company's ability to record,
               process, summarize and report financial information; and

          (ii) any fraud, whether or not material, that involves management or
               other employees who have a significant role in the Company's
               internal control over financial reporting.



<PAGE>



Dated:  August 19, 2003



RAGHU KILAMBI
Raghu Kilambi,
Chief Executive Officer and Chief Financial Officer

<PAGE>